By selecting the Yes option, leaving Amgen.nl option you understand that you are leaving the corporate page of Amgen nl and that you will be redirected to another Internet site belonging to third parties, for whose content or opinions Amgen nl is not responsible and makes no representations regarding such content or its accuracy. By selecting this option and accessing linked third party sites, you understand that you do so at your own risk.
The website to which you will be redirected may be designed exclusively for residents of a particular country or countries, as advertised on that website. As a consequence, the website to which you will be directed may contain information on pharmaceutical products or indications that are not approved in nl. If You reside in a country other than the one to which such website is directed, please contact your local Amgen affiliate for the correct information on products in your country of residence.
The Dutch innovative medicines sector has a Code as of January 1, 2020, which describes the values of the sector and what the sector stands for. All drug companies that are members of the Association Innovative Medicines, including Amgen, have signed the Code. With this, the sector underlines its social responsibility.
The Code contains agreements on integrity, transparency, social responsibility and quality. It is a form of self-regulation, which is not without obligation. Unique is the independent Advisory Board that monitors if members adhere to the Code. In addition, the college can provide solicited and unsolicited advice so that the Code can develop further. The Advisory Board publishes also a public annual report.
Based on the findings of the Advisory Board, the Code can be adjusted annually.